Transcribed

Transcribed

Business EN ↓ 23 episodes

Transcribed is your front-row seat to the fascinating world of biotech. Hosted by two curious minds bridging science and business, this podcast brings you insightful conversations with leading voices in biotechnology. Whether you're a student navigating STEM or business, or simply a curious listener, Transcribed delivers practical tools, career advice, and behind-the-scenes stories that make the complex world of biotech accessible and inspiring.

Be sure to visit the podcast's website and support the creator: podcasters.spotify.com

Author

Transcribed

Category

Business

Podcast website

podcasters.spotify.com

Latest episode

Nov 17, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Longevity Needs Proof, Not Shiny Objects | Brian Kennedy on Aging Clocks & Human Trials 17.11.2026

What would it take to prove that longevity medicine works? Professor Brian Kennedy, Distinguished Professor of Biochemistry and Physiology at the National University of Singapore and former president and CEO of the Buck Institute, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin. As a PhD student in Leonard Guarente's lab...

Every Embryo Resets Its Biological Age. Why? | Maria Marinova on Rebuilding Aging Science 10.11.2026

Every new organism starts young, even though it is made from old cells. How? Dr. Maria Marinova, co-scientific director of the Thalion Initiative, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin. Maria has wanted to work on aging since high school. She did research at Berkeley, EMBL, Cancer Research UK and LMU Munich, th...

Will Death Be Optional by 2045? | José Luis Cordeiro on Curing Aging 03.11.2026

Is aging a disease we can cure, and could death really become optional by 2045? José Luis Cordeiro, MIT-trained engineer, futurist and founding faculty member at Singularity University, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin. José spent his early career in energy. Then Shinya Yamanaka's 2012 Nobel Prize, which h...

How Fast Are You Really Aging? | Dr. Berit Hippe on Biological Age Tests 27.10.2026

Can a few drops of blood tell you how fast you're aging, and what to eat about it? Dr. Berit Hippe, nutrition scientist and co-founder of HealthBioCare in Vienna, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin. Berit's team brought one of the first biological age tests to the German-speaking market in 2014, combining te...

What Actually Slows Aging (and What Doesn’t) | Buck Institute CEO Eric Verdin 20.10.2026

Can you supplement your way to a longer life? Dr. Eric Verdin, president and CEO of the Buck Institute for Research on Aging, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at the Longevity Summit in Dublin. Eric trained as an MD in endocrinology, became a virologist at the start of the HIV epidemic, and his lab went on to clone the HDACs, a family of e...

Should We Kill Our Zombie Cells? | Prof. Lynne Cox on Senescence & Aging 13.10.2026

Why do old cells refuse to die, and should we get rid of them? Professor Lynne Cox, a biochemist and biogerontologist who spent nearly three decades at Oxford studying where aging begins inside the cell, joins Pierre Jacob and Meronn Jacob on Transcribed. We recorded this conversation in person at a longevity conference in Dublin. Lynne explains cellular senescence from the ground up: why cells st...

Why Fruit Flies Might Hold the Key to Aging | Kennedy Schaal 06.10.2026

What can a fruit fly teach us about living longer? Kennedy Schaal, known in longevity circles as "the fly queen", joins Pierre Jacob and Meronn Jacob on Transcribed. She has spent nearly 20 years breeding long-lived Methuselah flies and working out which genes help them outlive their peers. Kennedy tells us how a first-year lecture by Michael Rose at UC Irvine pulled her away from a care...

Can We Really Slow Aging? | Matt Kaeberlein on Rapamycin & Longevity 29.09.2026

What would it take to turn promising aging research into longer, healthier lives? Dr. Matt Kaeberlein joins Pierre Jacob and Meronn Jacob on Transcribed for a conversation about longevity science, the evidence behind rapamycin, and the personal story that helped inspire the Dog Aging Project. Matt explains how a talk at MIT drew him into aging research, why he challenges claims that get ahead of t...

What It Takes to Make Longevity Medicine Work | Prof. Andrea B. Maier 22.09.2026

What does it take to turn longevity research into medicine people can rely on? Prof. Andrea B. Maier joins Pierre Jacob and Meronn Jacob on Transcribed to discuss precision geromedicine, the work of preserving health and function as we age, and the standards needed to bring this approach into wider clinical practice. Andrea explains how she approaches a first clinic visit, why a person's goals...

From Research to a Fundable Biotech Startup | Bodo Brückner 15.09.2026

What has to happen between a promising research paper and a biotech company someone is willing to fund? Bodo Brückner joins Pierre Jacob and Meronn Yoshiyama to explain how the Life Science Accelerator Baden-Württemberg helps teams work toward investment readiness, and what scientists need to understand when they start building a business. Bodo describes an entrepreneurship course in which student...

Longevity for Everyone: Lessons from 39 Countries | Marek Piotrowski 08.09.2026

A year on the road. Five continents. Thirty-nine countries. More than 100 conversations with scientists. Marek Piotrowski set out with his son to explore what it takes to live longer. One of his biggest lessons came from the relationship they built along the way. In this episode of Transcribed, Pierre and Meronn sit down with Marek to discuss his move from marketing strategy into longevity, the le...

Can We Print Human Organs? Why Cells Need a Home | Ahed Almalla 01.09.2026

As co-founder of Renatrix, Dr. Ahed Almalla is building a future where cells "feel at home" — using advanced biomaterials to create 3D microenvironments that better mimic human biology. In this episode, she shares her incredible journey from war-torn Aleppo to founding a biotech startup in Berlin, how she shifted from academic perfectionism to entrepreneurial action, and her vision for 3D bioprint...

The Stem Cells Nobody Wanted: A Father’s Discovery | Yuta Lee 25.08.2026

As a founder and CEO of Accelerated Biosciences, Yuta Lee made an unlikely leap from a career in finance and insurance to building one of the most unusual stem cell platforms in regenerative medicine. He's commercializing a cell type discovered by his own father, one that might hold the key to fighting aging at its root. In this episode, Yuta unpacks his journey from property casualty insurance to...

This Scientist Builds Cells Out of Origami | Prof. Kerstin Goepfrich 30.06.2026

Welcome back to Transcribed, the podcast where we unpack the minds building the future of biotech. Today's guest, Professor Dr. Kerstin Goepfrich, is asking one of the most fundamental questions in all of science: what is life, and can we build it from scratch? As a full professor at Heidelberg University and group leader at the Max Planck Institute for Medical Research, she is one of the world's...

Germany Has the Science. Where is the money? 18.06.2026

After four decades at the intersection of science, industry, and strategy — from the DKFZ bench to 14 years in pharma R&D to two decades writing the EY Biotech Report — Dr. Siegfried Bialojan has watched German biotech ask the same question for 25 years: why doesn't the money show up? In this episode, he explains why Germany has never built a venture capital culture, the Strüngmann bet on...

How to Fund a Biotech Startup (Without Killing It) | Dr. Andreas Schmidt, Springboard Health Angels 02.06.2026

From starting and selling companies across three continents to backing the next wave of European biotech, Dr. Andreas Schmidt now sits at the intersection of founder, operator, and investor. In this episode, he explains why "venture capital is the most expensive money" and when founders should reach for it last, what most investors miss when evaluating early-stage biotech, and the "...

Inside Europe's Biotech Powerhouse | Dr. Julia Schaft (BioRN) 30.04.2026

As managing director of BioRN, Dr. Julia Schaft sits at the center of one of Europe's most powerful biotech ecosystems — connecting world-class research institutions, startups, and 9 of the top 20 global pharma companies within the Heidelberg region. In this episode, she unpacks why Europe keeps losing biotech companies to the US, how Germany's risk-averse culture holds back innovation, an...

From CRISPR to Programmable Biology | Prof. Dominik Niopek 31.03.2026

From dreaming of becoming a pilot to engineering proteins with light, Prof. Dr. Dominik Niopek sits at the cutting edge of programmable biology — building tools that let scientists control gene editing with a laser beam. In this episode, he walks us through how CRISPR went from a test tube experiment to an FDA-approved therapy in just 12 years, why humanoid robots might soon asist PhD students at...

Can AI Cure Disease Before It Starts? 25.02.2026

Abdelrahman Mahmoud explains how his company CellRewire is building AI architectures that can predict disease onset years before symptoms appear and computationally reprogram diseased cells back to healthy states. The conversation spans the fundamentals of single-cell genomics, why existing foundation models in biology have underdelivered, and how reinforcement learning agents can compress decades...

CEO of PEPperPRINT: We could prevent pandemics much better. 28.12.2025

Dr. Volker Stadler, CEO of PEPperPRINT, explains how his Heidelberg-based company uses a modified laser printer to synthesize peptide microarrays — a technology that maps how the immune system responds to viruses, vaccines, and autoimmune conditions with amino-acid-level precision. The conversation covers PEPperPRINT's pivotal role during the early days of COVID-19, the realities of bootstrapp...

Epigenetics expert: You might live longer than you think ! 02.12.2025

Dr. Axel Schumacher recounts how he pioneered the epigenetic microarray assay technology — a breakthrough that allows scientists to measure DNA methylation patterns across the entire genome, something a famous professor once told him would be impossible for 50 years. The conversation dives deep into epigenetic clocks, biological aging, and the tantalizing possibility of reversing aging altogether....

Startup CEO: Gene Therapy for the Heart is coming! 01.11.2025

Professor Patrick Most traces the 25-year journey from discovering a molecule that enhances heart contractility during his doctoral thesis, through founding two biotech startups, to his current company Aavigen's mission to deliver the first cardiac gene therapy via a simple intravenous injection by end of 2027. A masterclass in how academic scientists can navigate the path from lab bench to cl...

#Pilot: Christian Tidona 24.06.2025

Dr. Christian Tidona, founder and CEO of BioMed X, shares his journey from a PhD in virology to building one of Heidelberg's most innovative biotech research institutes — without taking a single euro of venture capital. He reveals the hard-won lessons from a failed first startup with striking parallels to the Theranos scandal, the critical role of trust and mentors, and why Heidelberg's wa...

Listen to the Transcribed podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.